Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 3, 2014, Pages 256-262

  Sung, Ki Chul ^a   Cha, Sung Chul ^a   Sung, Joo Wook ^a   So, Min Suk ^a   Byrne, Christopher D ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Atherosclerosis; Cardio metabolic risk factors; Coronary artery calcium (CAC) score; Fatty liver; Metabolic syndrome (MetS); Metabolically healthy obese; Non alcoholic fatty liver disease (NAFLD)

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL EVALUATION; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; EXERCISE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; STRUCTURED QUESTIONNAIRE; WAIST CIRCUMFERENCE;

ATHEROSCLEROSIS; CARDIO-METABOLIC RISK FACTORS; CORONARY ARTERY CALCIUM (CAC) SCORE; FATTY LIVER; METABOLIC SYNDROME (METS); METABOLICALLY HEALTHY OBESE; NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD);

ADULT; ATHEROSCLEROSIS; BODY MASS INDEX; COHORT STUDIES; FATTY LIVER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; REPUBLIC OF KOREA; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84895827988     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.07.005     Document Type: Article

References (30)

1. McKeigue P.M., Shah B., Marmot M.G. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991, 337:382-386.
2. Hu F.B., Willett W.C., Li T., Stampfer M.J., Colditz G.A., Manson J.E. Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med 2004, 351:2694-2703.
3. Katzmarzyk P.T., Janssen I., Ross R., Church T.S., Blair S.N. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care 2006, 29:404-409.
4. Bergman R.N., Kim S.P., Hsu I.R., Catalano K.J., Chiu J.D., Kabir M., et al. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med 2007, 120:S3-S8. discussion S29-32.
5. Ortega F.B., Lee D.C., Katzmarzyk P.T., Ruiz J.R., Sui X., Church T.S., et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013, 34:389-397.
6. Stefan N., Kantartzis K., Machann J., Schick F., Thamer C., Rittig K., et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008, 168:1609-1616.
7. Meigs J.B., Wilson P.W., Fox C.S., Vasan R.S., Nathan D.M., Sullivan L.M., et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006, 91:2906-2912.
8. St-Pierre A.C., Cantin B., Mauriege P., Bergeron J., Dagenais G.R., Despres J.P., et al. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ 2005, 172:1301-1305.
9. Arnlov J., Ingelsson E., Sundstrom J., Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010, 121:230-236.
10. Greenland P., LaBree L., Azen S.P., Doherty T.M., Detrano R.C. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. J Am Med Assoc 2004, 291:210-215.
11. Rhee E.J., Lee W.Y., Cho Y.K., Kim B.I., Sung K.C. Hyperinsulinemia and the development of nonalcoholic fatty liver disease in nondiabetic adults. Am J Med 2011, 124:69-76.
12. Targher G., Day C.P., Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010, 363:1341-1350.
13. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International diabetes Federation Task Force on epidemiology and prevention; National heart, Lung, and blood Institute; American heart association; World heart Federation; International atherosclerosis Society; and International association for the study of obesity. Circulation 2009, 120:1640-1645.
14. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
15. Saverymuttu S.H., Joseph A.E., Maxwell J.D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 1986, 292:13-15.
16. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15:827-832.
17. Hamer M., Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012, 97:2482-2488.
18. Despres J.P. What is "metabolically healthy obesity"?: from epidemiology to pathophysiological insights. J Clin Endocrinol Metab 2012, 97:2283-2285.
19. Byrne C.D., Olufadi R., Bruce K.D., Cagampang F.R., Ahmed M.H. Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci (Lond) 2009, 116:539-564.
20. Sung K.C., Jeong W.S., Wild S.H., Byrne C.D. Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes. Diabetes Care 2012, 35:717-722.
21. Musso G., Gambino R., Cassader M., Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011, 43:617-649.
22. Newsome P.N., Allison M.E., Andrews P.A., Auzinger G., Day C.P., Ferguson J.W., et al. Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis. Gut 2012, 61:484-500.
23. Lee K. Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors. Asia Pac J Clin Nutr 2009, 18:280-284.
24. Karelis A.D., Brochu M., Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)?. Diabete Metab 2004, 30:569-572.
25. Iacobellis G., Ribaudo M.C., Zappaterreno A., Iannucci C.V., Leonetti F. Prevalence of uncomplicated obesity in an Italian obese population. Obes Res 2005, 13:1116-1122.
26. Browning J.D., Szczepaniak L.S., Dobbins R., Nuremberg P., Horton J.D., Cohen J.C., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
27. Hamaguchi M., Kojima T., Itoh Y., Harano Y., Fujii K., Nakajima T., et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007, 102:2708-2715.
28. Ballestri S., Lonardo A., Romagnoli D., Carulli L., Losi L., Day C.P., et al. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. Liver Int 2012, 32:1242-1252.
29. Sookoian S., Gianotti T.F., Rosselli M.S., Burgueño A.L., Castaño G.O., Pirola C.J. Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease. Atherosclerosis 2011, 218:378-385.
30. Lee D.C., Sui X., Church T.S., Lee I.M., Blair S.N. Associations of cardiorespiratory fitness and obesity with risks of impaired fasting glucose and type 2 diabetes in men. Diabetes Care 2009, 32:257-262.